Clusters 1 through 4

Wish you would just tell the company mgmt., why don't they just be honest with everyone and disclose the direction of the sales force since they have been discussing for months and know whether cuts will occur or not. Wouldn't that be the normal, right, and decent way. Why don't you ask that, captain obvious. That's right, its a good thing for a company to be this dysfunctional and not care about their people. Getting to the truth is not called negative, its called the decent thing to do.

 

These are two completely different things. I stated we promoted Lipitor to the very end. I stated I don't believe the layoffs this round will be as big as the Dec. 2012 layoffs. How am I trying to have it both ways? I NEVER said don't worry! Where do you come up with this stuff. I pasted my original post below, READ it dumbass.

I clearly state there will be cuts. I understand you're nervous, as we all are, but seriously you need to chill out. Let me restate my opinion: Celebrex, Lyrica, and E are extremely important to Pfizer's long term plans/success. I don't see them cutting 40% of the sales force until we've squeezed every dollar from these franchises.

By the way, a diatribe is a forceful and bitter verbal attack (which is what you did), you probably meant to call my post a tirade.


Just because people don't agree with you doesn't mean they're stupid. If you look back at Lipitor, you'll remember it was in our bag until the very last minute. We were dropping the $4 cards by the truck load. Based on Lipitor it's not out of the realm of possibilities we see Celebrex in Cluster 1's hands until LOE or close to it.

What you really need to look at is what are Pfizers most important (meaning highest volume and potential today and tomorrow) drugs? #1 - Lyrica, #3 Celebrex. Tomorrows big drugs- eliquis. Pristiq isn't in the top 10.

DLA revenue down and dropping, Viagra flat, Chantix flat, Toviaz ha, Spiriva our take WAY DOWN.

Pfizer continues to hemorrhage volume/revenue. The size of the sales force is predicated on the revenue/potential the clusters produce. And the potential downsize of reducing promotional efforts (including ads, sales reps, prom. materials, RAMP letters, T&E expense).

In my opinion the cuts will NOT be as large as last years PC cuts. I envision Cluster's 1 & 2 promoting E perhaps even merging. Cluster 3 will have sole V resp. plus Toviaz, Cluster 4 will be cut. Pristiq promotion will be reduced on our end and increased on AZ side.

My opinion only, I'm making an educated guess without knowing more than 20% of the factors used to make decisions.

 

Cluster 4 DBMs were asked which of their reps have psych experience. Maybe Pfizer is thinking about ending the contract with AZ?

 

This comment ties in with other posts that have speculated that full time Pfizer reps will call on specialists only... cardiologists, urologists etc. and now psychs. Could it mean primary care docs will be covered by CSO rep?

 

Why all the speculation. Just pick up the phone, call the Regional, or VP of PC, or send an email to Ian Read for that matter, and ask if there will be layoffs or not. They already know the answer. Why is Pfizer keeping everyone in the dark, I thought they were supposed to promote transparency. Kind of "Jerky" if you ask me.

 

comments on interesting post dated 8/18?



Transformation shift is an understatement. DBMs are no longer needed and will be cut in half (minimum).

"Account Team" approach in major cities where there are large ACO's/IDS, etc.

KAMs will have oversight for the coordination of teams in these ACO's/IDS. Due to the number of KAMs Pfizer has, KAMs are going to be placed based on the last 2 years of performance. 1 KAM per state unless there are several large accounts in the state.

Teams will consist of several reps (covering all products) working together with the KAM. Incentives will be team and account driven.

Those DBM's who remain will be involved in only the coaching and administrative aspect of the team members. DBM's will also be aligned to several ACO/IDS teams. This is why the reduction in DBM's. It's the last 2 years performance (this year will not count).

Cluster 1 and 2 SHR's will remain (Relationships, BMS contract Pain products). PHR's in cluster 2 will be be thrown into the pool with cluster 1, 3 and 4 PHR's to determine who remains to sell those products that don't go to Contract Sales. In rural areas where there are independents, all clusters will be thrown into a pool (good luck).

RBD's are not needed in their current role and can expect significant role and scope changes. RM's will take on more responsibility with less geography. Several RM's will report into 1 RBD. RM's will have all ACO/IDS and all revenue responsibility for all products in their assigned geography. KAM's and DBM's will report into RM's. Streamlined.

This is the only model that can meet the needs of the changing Health Care environment. We all knew it was coming.

Specialty will also be members of the same team working the ACO's/IDS. PCP DBM's and Specialty DBM's covering the same geography is another reason for significant DBM reduction. DBM's in both Specialty and PCP will be slotted.

Summary;

1 RBD = Several RM's = a few states = many ACO's/IDS = KAMs and DBM's = Individual ACO/IDS team members = all products = smaller geography.

Teams; 1 Pain, 1 Cardiovascular, 1 Rheumatology, 1 Oncology, 1 Vaccines, 1 Rare Disease, etc, aligned to an ACO/IDS, KAM and DBM. DBM is the filter for the KAM B/W sales and C Selling.

Good luck.

 

If true middle management is toast. Ouch!

 

Nice post, but perhaps you should look at recent news on Pfizer. When you do you'll notice Pfizer is changing to three division model. 1. Products going generic after 2105 mostly pills, 2. Vacc, Onc., consumer products 3. value products.

Why the hell would Pfizer go through the trouble of breaking into 3 new selling groups if there was any chance your suggestion was an option? Onc./vacc not aligned with the other product divisions. You've posted this before, and I busted your "fiction" then. Are you saying the V/O division will allow it's reps to report to a DBM/RM not aligned to division? I think not

Try again

 

Did today's Fireside chat reveal anything regarding clusters?

 

fireside chat?? was there even a fire?

 

Today's fireside chat revealed nothing once again!!

 

did they make s'mores? any tall tales or spooky stories? or was it just plain bs? do tell...

 

We sang Kumbaya.